Cargando…
Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls
Hyaluronic acid (HA) is a key component of the extracellular matrix. HA and its metabolism are suggested to be altered in the lungs of patients with chronic obstructive pulmonary disease (COPD). The present study explored systemic HA, and its metabolic regulators, in patients with clinically stable...
Autores principales: | Waeijen-Smit, Kiki, Reynaert, Niki L., Beijers, Rosanne J. H. C. G., Houben-Wilke, Sarah, Simons, Sami O., Spruit, Martijn A., Franssen, Frits M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342478/ https://www.ncbi.nlm.nih.gov/pubmed/34354097 http://dx.doi.org/10.1038/s41598-021-95030-6 |
Ejemplares similares
-
All-cause admissions following a first ever exacerbation-related hospitalisation in COPD
por: Waeijen-Smit, Kiki, et al.
Publicado: (2023) -
Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease
por: Waeijen-Smit, Kiki, et al.
Publicado: (2021) -
Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study
por: Waeijen-Smit, Kiki, et al.
Publicado: (2023) -
Sputum microbiology predicts health status in COPD
por: Braeken, Dionne CW, et al.
Publicado: (2016) -
Comprehensive Lung Function Assessment Does not Allow to Infer Response to Pulmonary Rehabilitation in Patients with COPD
por: Augustin, Ingrid M. L., et al.
Publicado: (2018)